ANA News
2021-07-13 – For this month’s ANA Q&A, the ANA spoke with Nina Riggins, MD, PhD, a neurologist and associate professor at UCSF Health who specializes in headache medicine. Dr. Riggins discusses the public’s misunderstanding of headaches, how treatments have greatly improved over the years, and more. What…
2021-07-06 – The National Institute of Neurological Disorders and Strokes (NINDS) announced that starting in 2022 (application deadline in Fall 2021), the National Institutes of Health (NIH) will add a major new category of research that is eligible for Loan Repayment Program (LRP) support. This new LRP…
2021-06-29 – Physicians practicing in the neurologic subspecialty of Interventional Neurology subspecialty and sponsoring and parent organization members are invited to comment on the proposed Interventional Neurology Certification Examination content outline and certification eligibility requirements. Comments…
2021-06-24 – The Patient-Centered Outcomes Research Institute (PCORI) will be releasing the “Comparative Effectiveness of Novel Pharmacologic and Evidence-based Nonpharmacologic Treatments for Migraine Prevention” Targeted PCORI Funding Announcement (PFA) on September 7, 2021. This Targeted PFA seeks to fund…
2021-06-24 – ANA member David Dickoff, MD, shares fascinating insights in a recent SingleCare article about "7 Causes of Muscle Aches." Dr. Dickoff, neurologist and assistant clinical professor of neurology with Mount Sinai Hospital, says: “Muscle pain that occurs after exercise is pretty normal in most people…
2021-06-23 – NIH Director Francis Collins, MD, PhD, reported on June 10 that the first infrastructure awards supporting the RECOVER (REsearching COVID to Enhance Recover) Initiative, previously known as the Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Initiative, have been allocated. These and additional…
2021-06-18 – EVENT TITLE: Dialogue: Current Perspectives on Aducanumab DATE/TIME: June 21, 2021 (10 am - 2pm CT) AUDIENCE: Open to All OBJECTIVE: On June 7, 2021, the FDA made a decision to approve Biogen’s BLA submission of aducanumab for the treatment of Alzheimer’s disease. The Alzheimer’s Association has…
2021-06-18 – Check out these articles authored by ANA members recently accepted by and/or published in the Annals of Neurology: Characterization of Extracranial Giant Cell Arteritis with Intracranial Involvement and its Rapidly Progressive SubtypeReply to: Neurofilament Light Chain in Patients with COVID-19 and…
2021-06-17 – The American Brain Coalition, American College of Neuropsychopharmocology, Allen Institute, International Neuroethics Society, The Kavli Foundation, Simons Foundation and Society for Neuroscience, in cooperation with the Congressional Neuroscience Caucus,are hosting a Virtual Briefing celebrating…
2021-06-16 – With the widespread use of vaccines to protect against infection by the SARS-Cov2 virus, there is intense interest in possible low-frequency but clinically significant complications. Annals of Neurology announces two new research articles, one from India and one from England, both reporting…